Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study. - Smith, Graham H R; Henry, W Keith; Podzamczer, Daniel; Masiá, Maria Del Mar; Bettacchi, Christopher J; Arasteh, Keikawus; Jaeger, Hans; Khuong-Josses, Marie-Aude; Montes-Ramírez, Maria Luisa; Stellbrink, Hans-Jürgen; Yazdanpanah, Yazdan; Richmond, Gary J; et al. (Open Forum Infectious Diseases, 2021)